**FOR IMMEDIATE RELEASE**

FOR IMMEDIATE RELEASE

EXCLUSIVE: AMY SCHUMER’S “ROUTINE” COLONOSCOPY EXPOSES BIG PHARMA’S LATEST GRAB – DOCTORS CALL FOR INQUIRY

LOS ANGELES, CA – In a move that has conspiracy theorists and medical ethics watchdogs raising eyebrows, comedian Amy Schumer has become the unlikely poster child for a controversial new corporate wellness protocol. The 43-year-old star underwent a “routine” colonoscopy this week, but not before promoting a highly specific, branded screening kit and a direct-to-consumer pharmaceutical line.

Insiders reveal that the “routine” procedure was anything but. Sources say Schumer was approached by a major pharmaceutical conglomerate to serve as the face of a new screening initiative aimed at millennials and Gen Z. The deal, rumored to be worth $8 million, leverages her massive social media following to normalize a procedure that independent experts warn may be medically unnecessary for her age and risk profile.

“This isn’t about Amy’s health,” says Dr. Helena Vance, a whistleblower and former FDA advisor. “It’s about creating a new market. They’ve convinced a young, healthy, low-risk celebrity to undergo a procedure that carries real risks—perforation, sedation complications—all to sell a narrative that everyone needs to be ‘screened’ by a for-profit entity immediately.”

Schumer’s own promotional content, which was quickly picked up by major news outlets, has been dissected by fact-checkers. The comedian claimed the procedure was “life-saving,” but critics point out that there is no peer-reviewed evidence supporting annual colonoscopies for asymptomatic individuals under 45 without a family history. The American Cancer Society’s recent guideline change? Funded in part by the same corporation.

“This is a textbook case of disease mongering,” adds Dr. Vance